• All sections
  • C - Chemistrymetallurgy
  • C07D - Heterocyclic compounds
  • C07D 491/22 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or in which the condensed system contains four or more hetero rings

Patent holdings for IPC class C07D 491/22

Total number of patents in this class: 1212

10-year publication summary

46
50
51
71
71
105
116
144
147
111
2017 2018 2019 2020 2021 2022 2023 2024 2025 2026

Principal owners for this class

Owner
All patents
This class
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
389
37
Gilead Sciences, Inc.
2231
23
Idemitsu Kosan Co., Ltd.
4251
21
Hangzhou Adcoris Biopharma Co., Ltd.
36
21
Merck Sharp & Dohme LLC
3736
16
Merck Patent GmbH
5735
14
Minghui Pharmaceutical (Hangzhou) Limited
47
14
Minghui Pharmaceutical (Shanghai) Limited
48
14
LG Chem, Ltd.
17937
13
Nuvalent, Inc.
89
13
Immunomedics, Inc.
239
11
Shanghai Hengrui Pharmaceutical Co., Ltd.
715
10
Shanghai Qilu Pharmaceutical Research and Development Centre Ltd.
118
10
Daiichi Sankyo Company, Limited
1891
9
Promega Corporation
588
9
Pinotbio, Inc.
49
9
ScinoPharm Taiwan, Ltd.
129
8
Shanghai Institute of Materia Medica, Chinese Academy of Sciences
875
8
Shionogi & Co., Ltd.
885
8
Abbvie Inc.
1822
7
Other owners 937